STOCK TITAN

[Form 4] JanOne Inc. Common Stock (NV) Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Virland A. Johnson, identified as the issuer's Chief Financial Officer, reported transactions dated 05/30/2025 under the issuer listed as ALT5 Sigma Corp (ALTS). On that date he received 25,000 common shares that vested as Restricted Stock Units under the company's 2024 Equity Incentive Plan at a reported per-share amount of $0.01, leaving him with 38,000 shares beneficially owned after the transaction. He also acquired 125,000 warrants with a conversion/exercise price of $9.31, exercisable on 05/30/2025 and expiring on 05/30/2030, representing the right to purchase 125,000 additional common shares. The Form 4 notes the RSUs vested on the transaction date and lists the holdings as direct beneficial ownership.

Virland A. Johnson, indicato come Chief Financial Officer dell'emittente, ha segnalato operazioni in data 05/30/2025 relative all'emittente ALT5 Sigma Corp (ALTS). In quella data ha ricevuto 25,000 azioni ordinarie che sono state assegnate come Restricted Stock Units nell'ambito del 2024 Equity Incentive Plan della società, al valore per azione dichiarato di $0.01, portando il suo totale a 38,000 azioni di proprietà beneficiaria dopo la transazione. Ha inoltre acquisito 125,000 warrant con prezzo di conversione/esercizio di $9.31, esercitabili il 05/30/2025 e scadenti il 05/30/2030, che conferiscono il diritto di acquistare 125,000 azioni ordinarie aggiuntive. Il Modulo 4 specifica che le RSU sono state vestite alla data della transazione e registra le partecipazioni come proprietà beneficiaria diretta.

Virland A. Johnson, identificado como Director Financiero de la emisora, informó transacciones con fecha 05/30/2025 en la emisora ALT5 Sigma Corp (ALTS). Ese día recibió 25,000 acciones ordinarias que se consolidaron como Restricted Stock Units bajo el 2024 Equity Incentive Plan de la compañía, a un valor por acción declarado de $0.01, quedando con 38,000 acciones de propiedad beneficiaria tras la operación. También adquirió 125,000 warrants con precio de conversión/ejercicio de $9.31, ejercitables el 05/30/2025 y con vencimiento el 05/30/2030, que otorgan el derecho a comprar 125,000 acciones ordinarias adicionales. El Formulario 4 señala que las RSU vencieron en la fecha de la operación y enumera las tenencias como propiedad beneficiaria directa.

Virland A. Johnson는 발행사의 최고재무책임자(CFO)로 기재되어 있으며, 발행사 ALT5 Sigma Corp (ALTS) 관련 거래를 05/30/2025자에 보고했습니다. 해당 일자에 그는 회사의 2024 Equity Incentive Plan에 따른 Restricted Stock Units로 25,000 보통주를 수령했으며, 신고된 주당 금액은 $0.01로 거래 후 실질적 보유 주식은 38,000주가 되었습니다. 또한 전환/행사가격이 $9.31125,000 워런트를 취득했으며, 이는 05/30/2025부터 행사 가능하고 05/30/2030에 만료되어 추가로 125,000 보통주를 매수할 권리를 제공합니다. Form 4에는 RSU가 거래일에 베스팅되었고 보유는 직접적 실소유로 기재되어 있다고 명시되어 있습니다.

Virland A. Johnson, indiqué comme directeur financier de l'émetteur, a déclaré des transactions datées du 05/30/2025 concernant l'émetteur ALT5 Sigma Corp (ALTS). À cette date, il a reçu 25,000 actions ordinaires qui ont été attribuées sous forme de Restricted Stock Units dans le cadre du 2024 Equity Incentive Plan de la société, au montant rapporté par action de $0.01, le portant à 38,000 actions détenues à titre de bénéficiaire après la transaction. Il a également acquis 125,000 warrants au prix de conversion/exercice de $9.31, exerçables le 05/30/2025 et arrivant à échéance le 05/30/2030, donnant le droit d'acheter 125,000 actions ordinaires supplémentaires. Le formulaire 4 indique que les RSU ont été vestées à la date de la transaction et présente les avoirs comme une propriété bénéficiaire directe.

Virland A. Johnson, als Chief Financial Officer des Emittenten angegeben, meldete Transaktionen vom 05/30/2025 für den Emittenten ALT5 Sigma Corp (ALTS). An diesem Datum erhielt er 25,000 Stammaktien, die als Restricted Stock Units gemäß dem 2024 Equity Incentive Plan des Unternehmens vested wurden, zum gemeldeten Stückpreis von $0.01, womit er nach der Transaktion 38,000 Aktien als wirtschaftlicher Eigentümer hielt. Zudem erwarb er 125,000 Warrants mit einem Umwandlungs-/Ausübungspreis von $9.31, ausübbar am 05/30/2025 und mit Ablaufdatum 05/30/2030, die das Recht verleihen, weitere 125,000 Stammaktien zu erwerben. Das Formular 4 vermerkt, dass die RSUs am Transaktionsdatum vested sind und führt die Bestände als direkte wirtschaftliche Inhaberschaft auf.

Positive
  • CFO received 25,000 vested RSUs under the 2024 Equity Incentive Plan, increasing direct ownership to 38,000 shares.
  • Acquisition of 125,000 warrants recorded with explicit terms: conversion price $9.31, exercisable 05/30/2025, expiring 05/30/2030, creating a clear, quantifiable upside if exercised.
Negative
  • None.

Insights

TL;DR: CFO received vested RSUs and warrants; transaction shows insider equity compensation rather than open-market purchase.

The filing documents a compensation-driven acquisition: 25,000 RSU shares vested (reported at $0.01 per share) and 125,000 warrants were recorded with a $9.31 exercise price and a 05/30/2030 expiry. For investors, the RSU vesting increases the CFO's direct stake to 38,000 shares, while the warrants, if exercised, could convert to 125,000 additional shares. This is a routine insider compensation disclosure; the filing does not report open-market buying or selling activity.

TL;DR: Routine equity-based compensation event disclosed; aligns executive incentives with shareholders but increases potential share count.

The Form 4 indicates the company used its 2024 Equity Incentive Plan to grant RSUs that vested and to record outstanding warrants tied to the CFO. Such grants are standard for retention and alignment purposes. The filing directly states vesting and the warrants' terms ($9.31 strike; exercisable 05/30/2025; expire 05/30/2030), allowing assessment of potential future dilution. There is no indication in the filing of departures, sales, or unusual trading arrangements.

Virland A. Johnson, indicato come Chief Financial Officer dell'emittente, ha segnalato operazioni in data 05/30/2025 relative all'emittente ALT5 Sigma Corp (ALTS). In quella data ha ricevuto 25,000 azioni ordinarie che sono state assegnate come Restricted Stock Units nell'ambito del 2024 Equity Incentive Plan della società, al valore per azione dichiarato di $0.01, portando il suo totale a 38,000 azioni di proprietà beneficiaria dopo la transazione. Ha inoltre acquisito 125,000 warrant con prezzo di conversione/esercizio di $9.31, esercitabili il 05/30/2025 e scadenti il 05/30/2030, che conferiscono il diritto di acquistare 125,000 azioni ordinarie aggiuntive. Il Modulo 4 specifica che le RSU sono state vestite alla data della transazione e registra le partecipazioni come proprietà beneficiaria diretta.

Virland A. Johnson, identificado como Director Financiero de la emisora, informó transacciones con fecha 05/30/2025 en la emisora ALT5 Sigma Corp (ALTS). Ese día recibió 25,000 acciones ordinarias que se consolidaron como Restricted Stock Units bajo el 2024 Equity Incentive Plan de la compañía, a un valor por acción declarado de $0.01, quedando con 38,000 acciones de propiedad beneficiaria tras la operación. También adquirió 125,000 warrants con precio de conversión/ejercicio de $9.31, ejercitables el 05/30/2025 y con vencimiento el 05/30/2030, que otorgan el derecho a comprar 125,000 acciones ordinarias adicionales. El Formulario 4 señala que las RSU vencieron en la fecha de la operación y enumera las tenencias como propiedad beneficiaria directa.

Virland A. Johnson는 발행사의 최고재무책임자(CFO)로 기재되어 있으며, 발행사 ALT5 Sigma Corp (ALTS) 관련 거래를 05/30/2025자에 보고했습니다. 해당 일자에 그는 회사의 2024 Equity Incentive Plan에 따른 Restricted Stock Units로 25,000 보통주를 수령했으며, 신고된 주당 금액은 $0.01로 거래 후 실질적 보유 주식은 38,000주가 되었습니다. 또한 전환/행사가격이 $9.31125,000 워런트를 취득했으며, 이는 05/30/2025부터 행사 가능하고 05/30/2030에 만료되어 추가로 125,000 보통주를 매수할 권리를 제공합니다. Form 4에는 RSU가 거래일에 베스팅되었고 보유는 직접적 실소유로 기재되어 있다고 명시되어 있습니다.

Virland A. Johnson, indiqué comme directeur financier de l'émetteur, a déclaré des transactions datées du 05/30/2025 concernant l'émetteur ALT5 Sigma Corp (ALTS). À cette date, il a reçu 25,000 actions ordinaires qui ont été attribuées sous forme de Restricted Stock Units dans le cadre du 2024 Equity Incentive Plan de la société, au montant rapporté par action de $0.01, le portant à 38,000 actions détenues à titre de bénéficiaire après la transaction. Il a également acquis 125,000 warrants au prix de conversion/exercice de $9.31, exerçables le 05/30/2025 et arrivant à échéance le 05/30/2030, donnant le droit d'acheter 125,000 actions ordinaires supplémentaires. Le formulaire 4 indique que les RSU ont été vestées à la date de la transaction et présente les avoirs comme une propriété bénéficiaire directe.

Virland A. Johnson, als Chief Financial Officer des Emittenten angegeben, meldete Transaktionen vom 05/30/2025 für den Emittenten ALT5 Sigma Corp (ALTS). An diesem Datum erhielt er 25,000 Stammaktien, die als Restricted Stock Units gemäß dem 2024 Equity Incentive Plan des Unternehmens vested wurden, zum gemeldeten Stückpreis von $0.01, womit er nach der Transaktion 38,000 Aktien als wirtschaftlicher Eigentümer hielt. Zudem erwarb er 125,000 Warrants mit einem Umwandlungs-/Ausübungspreis von $9.31, ausübbar am 05/30/2025 und mit Ablaufdatum 05/30/2030, die das Recht verleihen, weitere 125,000 Stammaktien zu erwerben. Das Formular 4 vermerkt, dass die RSUs am Transaktionsdatum vested sind und führt die Bestände als direkte wirtschaftliche Inhaberschaft auf.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Johnson Virland A

(Last) (First) (Middle)
325 E. WARM SPRINGS RD.

(Street)
LAS VEGAS NV 89119

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALT5 Sigma Corp [ ALTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
3. Date of Earliest Transaction (Month/Day/Year)
05/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/30/2025 A 25,000 A $0.01(1) 38,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (Right to Buy) $9.31 05/30/2025 A 125,000 05/30/2025 05/30/2030 Common Stock 125,000 $0 125,000 D
Explanation of Responses:
1. Restricted Stock Units were granted to the Reporting Person pursuant to the Issuer's 2024 Equity Incentive Plan, each of which vested on the Transaction Date.
Remarks:
/s/ Virland A. Johnson 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 and what is their role at ALT5 Sigma?

The Form 4 was filed by Virland A. Johnson, who is listed as the company's CFO.

What securities did the insider acquire on 05/30/2025?

The insider received 25,000 common shares from vested RSUs and acquired 125,000 warrants on 05/30/2025.

What were the terms of the warrants reported on the Form 4?

The warrants have a conversion/exercise price of $9.31, are exercisable on 05/30/2025, and expire on 05/30/2030, covering 125,000 common shares.

At what price were the RSU shares recorded?

The RSU shares were reported at a per-share amount of $0.01 in the Form 4.

How many common shares does the reporting person beneficially own after the transaction?

Following the reported transaction, the Form 4 lists the reporting person as beneficially owning 38,000 common shares.
JanOne Inc.

NASDAQ:JAN

JAN Rankings

JAN Latest News

JAN Latest SEC Filings

JAN Stock Data

27.14M
12.17M
0.93%
5.32%
1.36%
Waste Management
Pharmaceutical Preparations
Link
United States
LAS VEGAS